Pharmaceutical News

RSS

OncoThira and NDSU enter into license agreement to develop, market cancer compounds

The NDSU Research Foundation and OncoThira have entered into a license agreement involving technology developed at North Dakota State University.

14 Aug 2018

Long-term cannabinoid exposure impairs memory, study shows

A new study led by Ana Sebastião, group leader at Instituto de Medicina Molecular João Lobo Antunes and Professor of Faculdade de Medicina of Universidade de Lisboa and her team in collaboration with researchers from the University of Lancaster, shows that the long-term use of either cannabis or cannabis-based drugs impairs memory.

13 Aug 2018

Study: Patients taking OTC drugs, dietary supplements not aware of effects on lab test results

Over-the-counter drugs and dietary supplements are widely used and popular, with US households spending an average of almost USD 350 annually on OTC products. In 2006 an average of EUR 67.50 was spent per person on OTC products in Germany.

13 Aug 2018

Study may help increase effectiveness of antibiotics against drug-resistant bacteria

Bacteria - especially Gram-negative strains - are becoming increasingly resistant to current antibiotic drugs, and the development of new classes of antibiotics has slowed.

13 Aug 2018

Study shows link between use of benzodiazepines and increased risk of Alzheimer's disease

The use of benzodiazepines and related drugs (Z drugs) is associated with a modestly increased risk of Alzheimer's disease, according to a recent study from the University of Eastern Finland.

13 Aug 2018

FDA approves first oral medication for treatment of adults with Fabry disease

The U.S. Food and Drug Administration today approved Galafold (migalastat), the first oral medication for the treatment of adults with Fabry disease.

10 Aug 2018

Study finds prevalence of substandard and falsified medicines in developing countries

A new study from the University of North Carolina at Chapel Hill found that substandard and falsified medicines, including medicines to treat malaria, are a serious problem in much of the world.

10 Aug 2018

FDA approves first vaginal ring contraceptive that can be used for one year

The U.S. Food and Drug Administration today approved Annovera (segesterone acetate and ethinyl estradiol vaginal system), which is a combined hormonal contraceptive for women of reproductive age used to prevent pregnancy and is the first vaginal ring contraceptive that can be used for an entire year.

10 Aug 2018

Psychedelics may one day be used to treat mental health disorders

Many people think of psychedelics as relics from the hippie generation or something taken by ravers and music festival-goers, but they may one day be used to treat disorders ranging from social anxiety to depression, according to research presented at the annual convention of the American Psychological Association.

10 Aug 2018

FDA approves first targeted RNA-based treatment for rare, fatal genetic disease

The U.S. Food and Drug Administration today approved Onpattro (patisiran) infusion for the treatment of peripheral nerve disease (polyneuropathy) caused by hereditary transthyretin-mediated amyloidosis (hATTR) in adult patients.

10 Aug 2018

PARP inhibitors show promise for treating and preventing brain disorders

A class of cancer drugs called PARP inhibitors could be useful for treating and preventing brain disorders, including amyotrophic lateral sclerosis, also called Lou Gehrig's disease, and some forms of frontotemporal degeneration, by halting the misplacement of specific proteins that affect nerve cells, according to a study published in Molecular Cell by researchers in the the School of Arts and Sciences and the Perelman School of Medicine at the University of Pennsylvania.

10 Aug 2018

$Initiation of PIMs associated with higher risk of fracture-specific hospitalizations and mortality$

Initiation of PIMs associated with higher risk of fracture-specific hospitalizations and mortality

A recent study published in The European Journal of Health Economics finds that the initiation of potentially inappropriate medication is associated with a higher risk of fracture-specific hospitalizations and mortality.

10 Aug 2018

Trump administration sinks teeth into paring down drug prices, on 5 key points

Three months after President Donald Trump announced his blueprint to bring down drug prices, administration officials have begun putting some teeth behind the rhetoric.

10 Aug 2018

Clinicians who learn of a patient’s opioid death modestly cut back on prescriptions

Physicians and other medical providers modestly reduced the volume of opioids they prescribed after being told one of their patients had died of an overdose, according to research published Thursday.

10 Aug 2018

Collaboration between Merck and InnoCore could improve biologic drug delivery

Following today’s (Friday 3 August) announcement of Merck and InnoCore’s collaboration, Rahael Maladwala, Pharma Analyst at GlobalData, a leading data and analytics company, offers his view on what this might mean for biologic drug delivery:

10 Aug 2018

Physicians who come to know about overdose deaths reduce opioid prescription

Will clinicians become more careful in prescribing opioids if they are made of aware of the risks of these drugs first-hand?

10 Aug 2018

New combination therapy for cancer cells could soon be a reality

A new cancer therapy using nanoparticles to deliver a combination therapy direct to cancer cells could be on the horizon, thanks to research from the University of East Anglia.

From Precision NanoSystems Inc. 10 Aug 2018

Combination of arsenic and existing leukemia drug may combat cancer

Investigators have discovered that arsenic in combination with an existing leukemia drug work together to target a master cancer regulator.

9 Aug 2018

RNA and DNA sequencing platform matches broader swath of drugs to late-stage cancer patients

A comprehensive RNA and DNA sequencing platform benefits late-stage and drug-resistant multiple myeloma patients by determining which drugs would work best for them, according to results from a clinical trial published in JCO Precision Oncology in August.

9 Aug 2018

Proof-of-concept technology using nanoparticles could offer new approach for oral medications

Since the development of insulin to manage diabetes, pharmacists have longed to create an insulin pill. Past attempts have failed because insulin does not survive the harsh conditions of the gastro-intestinal system and cannot easily cross the GI wall.

9 Aug 2018

Pharmaceutical News

OncoThira and NDSU enter into license agreement to develop, market cancer compounds

Long-term cannabinoid exposure impairs memory, study shows

Study: Patients taking OTC drugs, dietary supplements not aware of effects on lab test results

Study may help increase effectiveness of antibiotics against drug-resistant bacteria

Study shows link between use of benzodiazepines and increased risk of Alzheimer's disease

FDA approves first oral medication for treatment of adults with Fabry disease

Study finds prevalence of substandard and falsified medicines in developing countries

FDA approves first vaginal ring contraceptive that can be used for one year

Psychedelics may one day be used to treat mental health disorders

FDA approves first targeted RNA-based treatment for rare, fatal genetic disease

PARP inhibitors show promise for treating and preventing brain disorders

Initiation of PIMs associated with higher risk of fracture-specific hospitalizations and mortality

Trump administration sinks teeth into paring down drug prices, on 5 key points

Clinicians who learn of a patient’s opioid death modestly cut back on prescriptions

Collaboration between Merck and InnoCore could improve biologic drug delivery

Physicians who come to know about overdose deaths reduce opioid prescription

New combination therapy for cancer cells could soon be a reality

Combination of arsenic and existing leukemia drug may combat cancer

RNA and DNA sequencing platform matches broader swath of drugs to late-stage cancer patients

Proof-of-concept technology using nanoparticles could offer new approach for oral medications

How does norepinephrine influence anxiety-related behaviours?

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Latest News